Background Elevated plasma total homocysteine (tHcy) predisposes to vascular disease and results from interactions between genetic and nutritional factors. MTHFR C 677 T increases tHcy in association with low folate. CBS 844ins68 lowers tHcy and negates the raising effect of MTHFR C 677 T in healthy subjects, but it is unclear if this is the case in subjects at high risk of vascular disease. This study examines the effect on plasma tHcy of interactions between these polymorphisms in an at-risk group.
Introduction
Hyperhomocystinaemia is a risk factor for cardiac, cerebral and peripheral vascular disease 1--3 and serum concentrations are determined by gene--gene and gene--vitamin interactions.
Homocysteine is produced by de-methylation of methionine. Approximately half is re-methylated by methionine synthase and its co-factor vitamin B 12 . 5-Methyl tetrahydrofolate is the methyl-donor for this step and is produced by the folic acid-dependent enzyme 5,10-methylene tetrahydrofolate reductase (MTHFR). Homocysteine is trans-sulphurated by condensation with serine to form cystathionine, catalysed by the vitamin B 6 -dependent enzyme cystathionine b-synthase (CBS). Genetic polymorphisms in these enzymes and de¢ciencies of their co-factors in£uence plasma total homocysteine (tHcy) concentrations and may predispose to vascular disease. A common mutation in the MTHFR gene (C 677 T) causes increased enzyme thermolability and reduced activity. 4 This results in an increase in plasma tHcy concentration and an associated increased risk of vascular disease in the TT and CT genotypes, 2 which is exacerbated in folate de¢ciency due to impaired re-methylation. A recently described polymorphism in the CBS gene, a 68 bp insertion in exon 8 (CBS 844ins68), appears to lower homocysteine concentrations. 5 This e¡ect may be potentiated by high vitamin B 6 levels. 6 Furthermore, possession of the CBS insertion negates the low folate-dependent homocysteine-raising e¡ect of the MTHFR TT genotype in healthy middle-aged men 7 and the healthy sons of men with premature myocardial infarctions. 8 It is not known if these interactions apply to a population of patients with cardiovascular disease associated with poor nutrition. The aim of this study was to investigate the relationship between MTHFR C 677 T and CBS 844ins68 genotypes, serum B 12 , B 6 and red cell folate concentrations on plasma tHcy in patients at high risk of vascular disease.
Materials and methods

Subjects
Fasting venous blood samples were collected from 376 subjects (244 men, 132 women; median age 53.3 years) at increased risk of coronary artery disease. Patients had either had a previous myocardial infarction, coronary artery bypass surgery, a family history of premature coronary heart disease, hyperlipidaemia or combinations of all of these. Ethical approval for the study was obtained from the Research Ethics Committee of the United Bristol Healthcare NHS Trust.
Sample collection
Samples for tHcy were immediately cooled in ice and separated within 30 min. Plasma was stored at À201C until analysis. Samples for red cell folate were stored at 41C for up to 48 h before haemolysate preparation and subsequently at À701C until analysis. Blood for vitamins B 12 and B 6 was centrifuged within 30 min and serum stored at À701C until analysis.
DNA extraction and genotyping
DNA was extracted from whole blood 9 and stored at À701C until analysis. The C 677 T mutation was analysed by PCR, followed by restriction digest with HinfI and separation of fragments by polyacrylamide gel electrophoresis. 4 CBS 844ins68 was identi¢ed by PCR and separation of the product on 2% agarose gel. 10 
Homocysteine and vitamin analysis
Plasma tHcy was measured following reduction of thiols with sodium borotetrahydride, derivatization with bromobimane and analysis by gradient elution on a reversed phase HLPC using a £uorimetric detector. Between batch coe⁄cient of variation (CV) was 4.1% at 12.2 mmol/L. Red cell folate and serum vitamin B 12 were measured by immunoluminometric assay with a Chiron Diagnostics ACS:180 analyser. Serum vitamin B 6 was measured by reversed-phase HPLC and £uorimetric detection. Between batch CV was 4.5% at 635 nmol/L for red cell folate, 2.7% at 488 pmol/L for B 12 and 6.3% at 114 nmol/L for B 6 .
Statistics
Homocysteine, vitamins B 12 , B 6 and folate concentrations showed skewed distributions and were therefore natural log transformed. Regression analysis was used to determine the relationship between homocysteine and the other analytes and their interactions. Di¡erences in tHcy concentrations between the genotype groups and vitamin quartiles were calculated using the Student's t-test. 
Results
Plasma homocysteine and vitamin concentrations
Genotype
The relationship between genotype and fasting plasma homocysteine concentration is illustrated in Figure 1D . This shows a clear association between hyperhomocysteinaemia and possession of the MTHFR TT genotype. The homocysteine-raising e¡ect of TT status was increased in the presence of a low folate or vitamin B 12 concentration (interactions Po0.05 and 0.01, respectively). The prevalence of MTHFR C 677 T was CC 42%, CT 48%, TT 10%; CBS 844ins68 prevalence NN 83%, NI 16%, II 0.3%, and is that typical of a UK population. 8 There was no interaction between the concentrations of serum vitamin B 6 or the other vitamins and CBS 844ins68 on plasma tHcy. Possession of the CBS 68 bp insertion did not in£uence plasma tHcy (P ¼ 0.82) and did not negate the MTHFR-raising e¡ects of the TT allele on plasma tHcy (P ¼ 0.40) ( Table 1 ).
Discussion
It is over 30 years since McCully 11 proposed that the elevated tHcy found in patients with homocystinuria, irrespective of aetiology, may be responsible for the development of premature vascular disease. However, the causal relationship between tHcy and vascular risk remains controversial 2,12 and is not fully understood. This lack of consensus arises partly because mild elevations of tHcy are only expressed in the presence of vitamin de¢ciencies and partly because meticulous care is required when blood is collected for tHcy analysis if spurious elevations are to be avoided. 13 Overall, the evidence indicates that raised tHcy results in vascular damage, genetic variants render patients prone to this and the tendency to hyperhomocysteinaemia is exacerbated by B vitamin de¢ciencies.
In this study we have measured tHcy, two common polymorphisms and B vitamin concentrations in a population of vascular high-risk patients. Meticulous attention has been paid to avoid elevated tHcy due to collection artefacts. The population was from an inner city area and likely to be at risk of poor nutrition. We have included vitamin B 6 measurement, often overlooked in other studies. Plasma tHcy was critically dependent upon folate, vitamin B 12 and vitamin B 6 . The homocysteine-raising e¡ect of the MTHFR TT phenotype was greater in the presence of low folate and vitamin B 12 concentrations, both essential for the re-methylation pathway. Unlike previous studies, 7, 8 we did not ¢nd an interaction between vitamin B 6 and CBS 844ins86. Furthermore, a recent study of healthy young people from Northern Ireland also reported no association between CBS844ins68 and tHcy. 14 Their study, like ours, used fasting subjects, which may explain the absence of an e¡ect of this polymorphism, but in addition poor vitamin B 6 status in our population may also be a contributing factor. We did not ¢nd that possession of the CBS 844ins68 prevented the homocysteine-raising e¡ect of the thermolabile form of MTHFR. This may be due to the relatively poor nutritional status of our patients compared with the young University students 7 or healthy middle-aged men 8 previously studied.
In a population at risk of coronary artery disease, we have con¢rmed the e¡ect of nutritional factors, including vitamin B 6 , on hyperhomocysteinaemia, and that these interact with MTHFR C 677 T, but not CBS 844ins68, in contributing to increased tHcy and thus to coronary artery disease risk.
